Cicero-Oneto Carlo Egysto, Mata-Valderrama Guadalupe, Valdez-Martínez Edith
Departamento de Hematooncología, Hospital Infantil de México Federico Gómez, SSA, México.
Coordinación de Investigación en Salud, IMSS. Ciudad de México, México.
Gac Med Mex. 2018;154(1):8-15. doi: 10.24875/GMM.17002698.
To describe the epidemiological, clinical, and ethical aspects of the mortality of young people with cancer in Mexico.
63 medical records from 14 to 18-year-old patients, with cancer, who died between 2011 and 2014, were reviewed to obtain epidemiological and clinical characteristics of their death. The study sites were three tertiary referral hospitals in Mexico City.
Of 40 young people in terminal phase, 16 (40%) continued to receive curative treatment; of the 51 whose place of death was known, 45 (88%) died in hospital. Of the 41 who died within 30 days of their last hospitalization, deaths were due to complications (51%), progression of the disease (41%), and deaths of those in palliative care (7%).
Oncological practice rests on what is known as a biomedical model. The results of this study suggest the urgent need for, and support the implementation of, true palliative-care services. More importantly, these findings underscore the necessity of putting the ethics of clinical practice into action, such that best practice in medicine is reinforced.
描述墨西哥癌症青少年患者死亡的流行病学、临床和伦理方面的情况。
回顾了2011年至2014年间在墨西哥城三家三级转诊医院死亡的14至18岁癌症患者的63份病历,以获取其死亡的流行病学和临床特征。
在40名终末期青少年患者中,16名(40%)继续接受根治性治疗;在已知死亡地点的51名患者中,45名(88%)在医院死亡。在最后一次住院30天内死亡的41名患者中,死亡原因包括并发症(51%)、疾病进展(41%)和姑息治疗患者死亡(7%)。
肿瘤学实践基于所谓的生物医学模式。本研究结果表明迫切需要并支持实施真正的姑息治疗服务。更重要的是,这些发现强调了将临床实践伦理付诸行动的必要性,从而强化医学最佳实践。